CRISPR gene therapy trial for sickle cell disease begins, offering hope for a potential cure by targeting the genetic root of ...
Beam’s CRISPR therapy for sickle cell yields consistent results with more patients In more sickle cell news, seven patients ...
UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...
A research group led by Jacob Corn has just discovered that the use of AZD7648 has serious side effects. The study has just ...
The payment scheme will tie gene therapy payments to improvements in health outcomes—and could potentially boost the uptake ...
The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% this year compared to 28% for the S&P 500. Will that trend continue in 2025 ...
Cathie Wood says a "cure" can generate up to 20x more value than traditional drugs, which appears to explain why two of her firm's funds snapped up shares of the Casgevy co-developer until this past ...
Vertex Pharmaceuticals Inc. and bluebird bio Inc. — are the first to take part in a new Medicaid model intended to expand ...